← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Cal-Maine had a very strong FY2025: revenue rose 83.2%, net income rose 339.0%, FCF rose 249.5%, and the forensic screen was safe.
The read at a glance✓ Audited against SEC data
- Business mix — Shell eggsNote
- Revenue — $4.26B, +83.2%OK
- Net income — $1.22B, +339.0%OK
- FCF — $1.06B, +249.5%OK
- Dividends — $330.3M, +259.6%OK
- Insiders — $9K purchase / 0 salesOK
- Accounting — Altman safe; EQ 100OK
Business
Cal-Maine produces, markets, distributes, and sells shell eggs, including conventional and specialty eggs.
Where the revenue comes from
Fiscal 2025, as CAL-MAINE FOODS INC reports it. History and quarterly detail are in the app.
- Retail$3.6B
- Non Specialty Shell Egg Sales$2.8B
- Specialty Shell Egg Sales$1.2B
- Foodservice$608.2M
- Egg Products$198.8M
Leadership changes
From CAL-MAINE FOODS INC's own filings, the day they're filed.
- Melanie Boulden · director · appointmenteff. 2025-09-01
- Dudley D. Wooley · director · appointmenteff. 2025-03-31
- Charles J. Hardin · President · departureeff. 2024-07-23
Latest filings
- 8-K · Company announcement2026-09-02
- DEF 14A · Annual proxy (pay & governance)2026-08-18
- 8-K · Company announcement2026-07-22
- 10-K · Annual report2026-07-22
- 8-K · Company announcement2026-06-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CAL-MAINE FOODS INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.